Skip to content
MS
rate-limiting unreviewed

Carbamoyl phosphate synthetase I (CPS I)

1 reactions · 1 pathways

Clinical / pharmacological. CPS I deficiency: hyperammonaemia, normal orotic acid

What it does, reaction by reaction

1 reactions

Urea Cycle Amino Acid & Nitrogen Metabolism · Mitochondrial matrix + cytosol

step 1 Irreversible rate-limiting

NH₄⁺ + HCO₃⁻ + 2 ATP → carbamoyl phosphate + 2 ADP + Pᵢ

Converts NH4+ HCO3- ATP into Carbamoyl phosphate ADP Pi

› Notes

In the mitochondrial matrix, carbamoyl phosphate synthetase I (CPS I) uses MgATP and requires N-acetylglutamate (NAG) as an obligatory allosteric activator. This is the rate-limiting, committed, and essentially irreversible step of the urea cycle; it consumes two high-energy phosphate bonds.

Showing all 1 reactions.

What accelerates and inhibits it

Regulation is pathway-specific, so each context is listed separately

1 entries

Urea Cycle

Accelerated by

N-acetylglutamate (obligatory); increased mitochondrial ammonia

Inhibited by

Absence of N-acetylglutamate; no principal direct physiologic inhibitor

Hormonal control

Glucagon and cortisol increase expression during fasting/high-protein catabolism; insulin lowers net ureagenic demand in the fed state

Recent literature

Europe PMC · fetched just now · sorted by publication date

  1. 1
  2. 2
    Neurotransmitter receptor-associated gene signature: prognostic and immunosuppressive microenvironment in NSCLC.

    Yang Y, Ge A, Xu Y, Li J, Shi W, Wang J, Zhao Z. · 2026-01-06

    open access unreviewed
  3. 3
    Essential Oral Single Nutritional Therapy Products for Inherited Metabolic Diseases: Evidence and Consensus Assessment Using a Modified Delphi Method.

    Stolwijk NN, Penninx BMF, Bosch AM, Langeveld M, Salomons GS, Hollak CEM, Essential Nutritional Therapy Produ… · 2026-11-01

    open access unreviewed
  4. 4
  5. 5
    Sustainable Water Remediation Through Degradation of Organic Pollutants Using Green‐Synthesized Cerium and Sulfur‐Doped TiO2 Nanoparticles

    Ullah F, Saifullah J, Rasheed S, Gul S, Sharif S, Abbas S, Khan M. · 2026-10-01

    open access unreviewed
  6. 6
    Determination of Gene-Level Fitness Contributions Across the Mucin-Utilization Network of Bacteroides thetaiotaomicron.

    Kim K, Lee J, Kang M, Yim SS, Choe D, Cho BK. · 2026-10-04

    open access unreviewed
  7. 7
  8. 8
    Gene variants associated with pediatric-onset erythromelalgia: Mendelian and rare-variant association analyses.

    Yonas MC, Ocay DD, Genetti CA, Lobo K, Fernandes M, Groussis N, Halpin M, Wilder RT, Yu TW, Berde CB, Brownst… · 2026-08-03

    open access unreviewed
  9. 9
  10. 10
    Advances in metabolic reprogramming of pulmonary fibrosis

    · 2026-09-01

    open access unreviewed

External claims. These come from an index outside this database and are not checked against it. Treat them as leads.